Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in the western world, and the mortality rate from PCa in Asia has been increasing recently. Statins are potent inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treating hyperlipidemi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Chen, Yu-An, Lin, Ying-Ju, Lin, Cheng-Li, Lin, Hwai-Jeng, Wu, Hua-Shan, Hsu, Hui-Ying, Sun, Yu-Chen, Wu, Hui-Yu, Lai, Chih-Ho, Kao, Chia-Hung
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874326/
https://ncbi.nlm.nih.gov/pubmed/29623039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00225
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados